140 related articles for article (PubMed ID: 21523732)
21. Influence of cigarette smoking on survival and tumor invasiveness in clinical stage IA lung adenocarcinoma.
Maeda R; Yoshida J; Ishii G; Hishida T; Nishimura M; Nagai K
Ann Thorac Surg; 2012 May; 93(5):1626-32. PubMed ID: 22421592
[TBL] [Abstract][Full Text] [Related]
22. ANCCA protein expression is a novel independent poor prognostic marker in surgically resected lung adenocarcinoma.
Zhang Y; Sun Y; Li Y; Fang Z; Wang R; Pan Y; Hu H; Luo X; Ye T; Li H; Wang L; Chen H; Ji H
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S577-82. PubMed ID: 23775406
[TBL] [Abstract][Full Text] [Related]
23. Prognostic impact of CD73 and A2A adenosine receptor expression in non-small-cell lung cancer.
Inoue Y; Yoshimura K; Kurabe N; Kahyo T; Kawase A; Tanahashi M; Ogawa H; Inui N; Funai K; Shinmura K; Niwa H; Suda T; Sugimura H
Oncotarget; 2017 Jan; 8(5):8738-8751. PubMed ID: 28060732
[TBL] [Abstract][Full Text] [Related]
24. Lysyl oxidase: A colorectal cancer biomarker of lung and hepatic metastasis.
Liu Y; Wang G; Liang Z; Mei Z; Wu T; Cui A; Liu C; Cui L
Thorac Cancer; 2018 Jul; 9(7):785-793. PubMed ID: 29766649
[TBL] [Abstract][Full Text] [Related]
25. MET gene copy number gain is an independent poor prognostic marker in Korean stage I lung adenocarcinomas.
Jin Y; Sun PL; Kim H; Seo AN; Jheon S; Lee CT; Chung JH
Ann Surg Oncol; 2014 Feb; 21(2):621-8. PubMed ID: 24212721
[TBL] [Abstract][Full Text] [Related]
26. Selective expression of lysyl oxidase (LOX) in the stromal reactions of broncho-pulmonary carcinomas.
Peyrol S; Galateau-Salle F; Raccurt M; Gleyzal C; Sommer P
Histol Histopathol; 2000 Oct; 15(4):1127-35. PubMed ID: 11005237
[TBL] [Abstract][Full Text] [Related]
27. Basigin expression as a prognostic indicator in stage I pulmonary adenocarcinoma.
Matsumoto T; Nagashio R; Ryuge S; Igawa S; Kobayashi M; Fukuda E; Goshima N; Ichinoe M; Jiang SX; Satoh Y; Masuda N; Murakumo Y; Saegusa M; Sato Y
Pathol Int; 2018 Apr; 68(4):232-240. PubMed ID: 29431238
[TBL] [Abstract][Full Text] [Related]
28. Expression of Lysyl Oxidase Predictive of Distant Metastasis of Laryngeal Cancer.
Lee YS; Park Y; Kwon M; Roh JL; Choi SH; Nam SY; Kim SY
Otolaryngol Head Neck Surg; 2017 Mar; 156(3):489-497. PubMed ID: 28116994
[TBL] [Abstract][Full Text] [Related]
29. [Effects of lysyl oxidase down-regulation on invasion, migration and E-cadherin protein expression of hypoxic lung cancer cells].
Wei L; Song XR; Sun JJ; Xie L; Wang XW; Lü LY
Zhonghua Yi Xue Za Zhi; 2012 Nov; 92(42):3004-7. PubMed ID: 23328296
[TBL] [Abstract][Full Text] [Related]
30. Expression of SIRT1 and cortactin is associated with progression of non-small cell lung cancer.
Noh SJ; Baek HA; Park HS; Jang KY; Moon WS; Kang MJ; Lee DG; Kim MH; Lee JH; Chung MJ
Pathol Res Pract; 2013 Jun; 209(6):365-70. PubMed ID: 23702379
[TBL] [Abstract][Full Text] [Related]
31. [Expression of LOX and MMP-2 in gastric cancer tissue and the effects of LOX and MMP-2 on tumor invasion and metastasis].
Ma LJ; Li YG; Huang L; Han M; Ma BJ; Sun BJ; Lin JJ; Song TG
Zhonghua Zhong Liu Za Zhi; 2011 Jan; 33(1):37-41. PubMed ID: 21575462
[TBL] [Abstract][Full Text] [Related]
32. Prognostic impact of preoperative monocyte counts in patients with resected lung adenocarcinoma.
Kumagai S; Marumo S; Shoji T; Sakuramoto M; Hirai T; Nishimura T; Arima N; Fukui M; Huang CL
Lung Cancer; 2014 Sep; 85(3):457-64. PubMed ID: 25043641
[TBL] [Abstract][Full Text] [Related]
33. [Mechanism of lysyl oxidase (LOX) in breast cancer invasion and metastasis].
Liu JL; Wei W; Tang W; Jiang Y; Yang HW; Li JT
Zhonghua Yi Xue Za Zhi; 2012 May; 92(20):1379-83. PubMed ID: 22883193
[TBL] [Abstract][Full Text] [Related]
34. The prognostic role of pathologic invasive component size, excluding lepidic growth, in stage I lung adenocarcinoma.
Tsutani Y; Miyata Y; Mimae T; Kushitani K; Takeshima Y; Yoshimura M; Okada M
J Thorac Cardiovasc Surg; 2013 Sep; 146(3):580-5. PubMed ID: 23778085
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of TAZ expression in resected non-small cell lung cancer.
Xie M; Zhang L; He CS; Hou JH; Lin SX; Hu ZH; Xu F; Zhao HY
J Thorac Oncol; 2012 May; 7(5):799-807. PubMed ID: 22481233
[TBL] [Abstract][Full Text] [Related]
36. Expression of the lysyl oxidase propeptide in hepatocellular carcinoma and its clinical relevance.
Zheng Y; Wang X; Wang H; Yan W; Zhang Q; Chang X
Oncol Rep; 2014 Apr; 31(4):1669-76. PubMed ID: 24573150
[TBL] [Abstract][Full Text] [Related]
37. Prognostic impact of GATA binding protein-3 expression in primary lung adenocarcinoma.
Hashiguchi T; Miyoshi H; Nakashima K; Yokoyama S; Matsumoto R; Murakami D; Mitsuoka M; Takamori S; Akagi Y; Ohshima K
Hum Pathol; 2017 May; 63():157-164. PubMed ID: 28322854
[TBL] [Abstract][Full Text] [Related]
38. Lysyl oxidase expression in bronchogenic carcinoma.
Woznick AR; Braddock AL; Dulai M; Seymour ML; Callahan RE; Welsh RJ; Chmielewski GW; Zelenock GB; Shanley CJ
Am J Surg; 2005 Mar; 189(3):297-301. PubMed ID: 15792754
[TBL] [Abstract][Full Text] [Related]
39. Human breast cancer cell metastasis is attenuated by lysyl oxidase inhibitors through down-regulation of focal adhesion kinase and the paxillin-signaling pathway.
Chen LC; Tu SH; Huang CS; Chen CS; Ho CT; Lin HW; Lee CH; Chang HW; Chang CH; Wu CH; Lee WS; Ho YS
Breast Cancer Res Treat; 2012 Aug; 134(3):989-1004. PubMed ID: 22434522
[TBL] [Abstract][Full Text] [Related]
40. Stromal invasion and micropapillary pattern in 212 consecutive surgically resected stage I lung adenocarcinomas: histopathological categories for prognosis prediction.
Yeh YC; Wu YC; Chen CY; Wang LS; Hsu WH; Chou TY
J Clin Pathol; 2012 Oct; 65(10):910-8. PubMed ID: 22813729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]